These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
47 related articles for article (PubMed ID: 375822)
21. Treatment of paediatric visceral leishmaniasis: amphotericin B or pentavalent antimony compounds? Kafetzis DA; Velissariou IM; Stabouli S; Mavrikou M; Delis D; Liapi G Int J Antimicrob Agents; 2005 Jan; 25(1):26-30. PubMed ID: 15620822 [TBL] [Abstract][Full Text] [Related]
22. Treatment of Candida glabrata infection in immunosuppressed mice by using a combination of liposomal amphotericin B with caspofungin or micafungin. Olson JA; Adler-Moore JP; Smith PJ; Proffitt RT Antimicrob Agents Chemother; 2005 Dec; 49(12):4895-902. PubMed ID: 16304150 [TBL] [Abstract][Full Text] [Related]
23. [Effect of amphotericin B on the energy metabolism of tissue forms of Candida albicans]. Arabiĭskiĭ RA; Mikhaĭlova NG Antibiotiki; 1979 Oct; 24(10):758-61. PubMed ID: 386938 [TBL] [Abstract][Full Text] [Related]
24. [Use of tablet forms of monomycin in children with acute dysentery]. Vershchagin IA; Ivanova SS; Bukhteeva ER; Mukhina LI; Golosnaia RD Antibiotiki; 1977 Nov; 22(11):1028-31. PubMed ID: 339824 [TBL] [Abstract][Full Text] [Related]
25. [Properties of a collagen and monomycin complex]. Rudenko TG; Dronov AF; Arutiunova VA; Vaisov ASh Antibiotiki; 1977 Mar; 22(3):239-42. PubMed ID: 322605 [TBL] [Abstract][Full Text] [Related]
26. [Comparative efficacy of the treatment of cutaneous leishmaniasis with monomycin when administered with hemodes and ecmoline]. Ereshov ME; Khaĭrulin FIa Med Parazitol (Mosk); 1987; (4):15-9. PubMed ID: 3119966 [No Abstract] [Full Text] [Related]
28. Chemotherapy of leishmaniasis: a method for screening potential leishmanicides. Mattock NM; Peters W Trans R Soc Trop Med Hyg; 1973; 67(1):22. PubMed ID: 4798215 [No Abstract] [Full Text] [Related]
29. The effect of ketoconazole and a combination of rifampicin/amphotericin B on cutaneous leishmaniasis in laboratory mice. Weinrauch L; El-On J Trans R Soc Trop Med Hyg; 1984; 78(3):389-90. PubMed ID: 6087514 [No Abstract] [Full Text] [Related]
30. [TESTS OF THE CHEMOTHERAPEUTIC ACTIVITY OF MONOMYCIN IN EXPERIMENTAL CUTANEOUS LEISHMANIASIS IN WHITE MICE]. KELLINA OI Med Parazitol (Mosk); 1963; 32():572-6. PubMed ID: 14053442 [No Abstract] [Full Text] [Related]
31. [Experience with therapy of patients with cutaneous leishmaniasis and organization of its prophylaxis]. Iarmukhamedov MA Voen Med Zh; 1977 Mar; (3):66-7. PubMed ID: 331665 [No Abstract] [Full Text] [Related]
32. [Pharmacokinetics of amphoglucamine in an experiment]. Fateeva LI Antibiot Med Biotekhnol; 1986 Apr; 31(4):280-3. PubMed ID: 3717925 [TBL] [Abstract][Full Text] [Related]
33. Combination therapy (monomycine and methyluracil) in leishmaniasis cutis. Hossain MZ Int J Dermatol; 1988 Dec; 27(10):720-2. PubMed ID: 3148561 [TBL] [Abstract][Full Text] [Related]
34. [What are the prospects for pharmacological treatment of prion disease?]. Adjou KT; Seman M Therapie; 2002; 57(2):123-7. PubMed ID: 12185959 [TBL] [Abstract][Full Text] [Related]
35. Antileishmanial activity of nano-amphotericin B deoxycholate. Manandhar KD; Yadav TP; Prajapati VK; Kumar S; Rai M; Dube A; Srivastava ON; Sundar S J Antimicrob Chemother; 2008 Aug; 62(2):376-80. PubMed ID: 18453526 [TBL] [Abstract][Full Text] [Related]
36. Efficacy and safety of liposomal amphotericin B (AmBisome) for visceral leishmaniasis in endemic developing countries. Berman JD; Badaro R; Thakur CP; Wasunna KM; Behbehani K; Davidson R; Kuzoe F; Pang L; Weerasuriya K; Bryceson AD Bull World Health Organ; 1998; 76(1):25-32. PubMed ID: 9615494 [TBL] [Abstract][Full Text] [Related]
37. [Effect of lipid preparations isolated from protozoa on experimental leishmaniasis in golden hamsters]. Saf'ianova VM; Emel'ianova LP; Sukhareva NN; Uriniuk VM Antibiotiki; 1978 Nov; 23(11):1918-24. PubMed ID: 363050 [TBL] [Abstract][Full Text] [Related]
38. [Comparative electron microscopic study of the ultrastructural changes in L. braziliensis promastigotes exposed to monomycin and amphoglucamine]. Delektorskiĭ VV; Tishchenko LD; Alita OV; Saf'ianova VM; Emel'ianova LP Med Parazitol (Mosk); 1982; 60(2):62-5. PubMed ID: 6806591 [No Abstract] [Full Text] [Related]
39. [Experimental characteristics of the antileishmaniasis action of amphotericin B]. Liubimov LK; Fateeva LI; Sergeeva LA Antibiotiki; 1979 Apr; 24(4):281-4. PubMed ID: 375822 [TBL] [Abstract][Full Text] [Related]